Use and Misuse of Nomograms for Prostate Cancer Detection Without Consideration of Analytical Differences Between PSA Assays

被引：0
|
作者：
Siemssen, K. [1 ]
Stephan, Carsten [1 ]
Cammann, Henning [1 ]
Jung, Klaus [1 ]
机构：
[1] Charite Univ Med Berlin, Dept Urol, Berlin, Germany
来源：
EUROPEAN JOURNAL OF MEDICAL RESEARCH | 2009年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
873
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [21] Correlation between initial total PSA and PSA velocity in men with and without biopsy-proven prostate cancer
    Bektic, Jasmin
    Pelzer, Alexandre E.
    Schaefer, Georg
    Bartsch, Georg
    Horninger, Wolfgang
    Leonhartsberger, Nicolai
    JOURNAL OF UROLOGY, 2007, 177 (04): : 581 - 581
  • [22] WHAT KIND OF DIFFERENCES ARE THERE BETWEEN BPH AND PROSTATE CANCER REGARDING PSA AND ITS DERIVATES?
    Ustun, Guven
    Altay, Baris
    Ekren, Fatih
    Turna, Burak
    Semerci, Bulent
    Cikili, Necmettin
    TURKISH JOURNAL OF UROLOGY, 2006, 32 (01): : 37 - 42
  • [23] Association between PSA density and prostate cancer in men without significant MRI lesions
    Mortezavi, Ashkan
    Eklund, Martin
    Bergman, Martin
    Kjosavik, Svein R.
    Discacciati, Andrea
    Nordstrom, Tobias
    BJU INTERNATIONAL, 2020, 125 (06) : 763 - 764
  • [24] Differences in prostate cancer detection between Canadian and Saudi populations
    Al-Abdin, O. Z.
    Rabah, D. M.
    Badr, G.
    Kotb, A.
    Aprikian, A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2013, 46 (06) : 539 - 545
  • [25] EVALUATION OF VARIETY AND PERFORMANCE BETWEEN PSA ASSAYS AND PHI IN A CLINICAL COHORT OF MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER
    Kaufmann, Basil
    Pellegrino, Paloma
    Lautenbach, Noemie
    Spanaus, Katharina
    von Eckardstein, Arnold
    Hermanns, Thomas
    Poyet, Cedric
    JOURNAL OF UROLOGY, 2022, 207 (05): : E189 - E189
  • [26] Relation between PSA level at initial screening and subsequent cancer detection in a prostate cancer screening study
    Antenor, JAV
    Roehl, KA
    Catalona, WJ
    JOURNAL OF UROLOGY, 2002, 167 (04): : 99 - 99
  • [27] The use of a third generation chemiluminescent PSA assay for the early detection of recurrent prostate cancer.
    Vallorosi, CJ
    Giacherio, DA
    Beduschi, MC
    England, BG
    Montie, JE
    Wojno, KJ
    CLINICAL CHEMISTRY, 1998, 44 : A38 - A38
  • [28] Midlife baseline PSA as a predictor of lethal prostate cancer: Racial differences between black and white men
    Chiarelli, G.
    Davis, M.
    Stephens, A.
    Finati, M.
    Cirulli, G.
    Morrison, C.
    Sood, A.
    Carrieri, G.
    Briganti, A.
    Montorsi, F.
    Lughezzani, G.
    Buffi, N.
    Rogers, C.
    Abdollah, F.
    EUROPEAN UROLOGY, 2024, 85 : S54 - S54
  • [29] MIDLIFE BASELINE PSA AS A PREDICTOR OF LETHAL PROSTATE CANCER: RACIAL DIFFERENCES BETWEEN BLACK AND WHITE MEN
    Chiarelli, Giuseppe
    Matthew, Davis
    Stephens, Alex
    Finati, Marco
    Cirulli, Giuseppe O.
    Morrison, Chase
    Tinsley, Shane
    Sood, Akshay
    Carrieri, Giuseppe
    Briganti, Alberto
    Montorsi, Francesco
    Lughezzani, Giovanni
    Buffi, Nicolo
    Rogers, Craig
    Abdollah, Firas
    JOURNAL OF UROLOGY, 2024, 211 (05): : E310 - E310
  • [30] Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: Impact of changing disease demographics
    Miller, MC
    O'Dowd, GJ
    Partin, AW
    Veltri, RW
    UROLOGY, 2001, 57 (06) : 1105 - 1111
12345